Allogeneic mesenchymal stem cells
Drug timelines are a Plus or Pro feature.
26 regulatory and trial events tracked for Allogeneic mesenchymal stem cells, covering 2009-08-11 to 2026-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Treatment of Severe Ocular Chemical Burns by Subconjunctival Injection of Allogeneic Mesenchymal Stem Cells: An Open-Label, Single-Arm, Multicenter Phase II Trial [Phase 2]